Skip to content
Global Sites
  • Facebook Icon
  • Facebook Icon
  • Facebook Icon
  • +91-22-2439 5200
  • Contact Us
J.B. Chemicals and Pharmaceuticals Ltd

JB Pharma

Just another WordPress site

  • Foundation
    • History
    • Board of Directors
    • Management Team
    • Our Responsibility
    • Our Philosophy
  • Manufacturing
    • Plants
  • Science
    • Lozenges
    • API
    • Radio Diagnostics
  • Therapies
    • Therapies at JB
    • International Portfolio
  • Global Presence
    • JB Business Worldwide
    • International Partnerships
  • Investor Information
    • Financial Information
    • Shareholders Corner
  • ESG
    • Home
    • Environment
    • Social
    • Governance
    • Community Development (CSR)
    • Impact That Matters (Case Studies)
    • Reports
    • Biomedical Waste Management
  • Media
    • Media Kit
  • Careers
Close
Arrow right
/home/jbphawtx/public_html/wp-content/themes/jbcpl/components/panel-content/panel-navigations/panel-navigation-1/panel-navigation-1.php on line 1
">
Global Sites
  • Facebook Icon
  • Facebook Icon
  • Facebook Icon
  • +91-22-2439 5200
  • Contact Us
  • Foundation
    • History
    • Board of Directors
    • Management Team
    • Our Responsibility
    • Our Philosophy
  • Manufacturing
    • Plants
  • Science
    • Lozenges
    • API
    • Radio Diagnostics
  • Therapies
    • Therapies at JB
    • International Portfolio
  • Global Presence
    • JB Business Worldwide
    • International Partnerships
  • Investor Information
    • Financial Information
    • Shareholders Corner
  • ESG
    • Home
    • Environment
    • Social
    • Governance
    • Community Development (CSR)
    • Impact That Matters (Case Studies)
    • Reports
    • Biomedical Waste Management
  • Media
    • Media Kit
  • Careers

Year: FY23-24

Image

Q2 FY24 Investor Presentation

READ MORE
Image

Q2 FY24 Press Release

READ MORE
Image

Q2 FY24 Results Sheet

READ MORE
Image

Notice of Board Meeting for Q2 results

READ MORE
Image

Statement of shares transferred to IEPF during FY 2023-24

READ MORE
Image

Statement showing holding of securities and shareholding pattern – Q2 2023-24

READ MORE
Image

Publication of 2nd Sustainability (ESG) Report

READ MORE
Image

Intimation of record date for Split/Sub-Division of Equity shares

READ MORE
Image

AGM Voting Results FY23-24

READ MORE
Image

Q1 FY 24 Earnings Call Transcript

READ MORE

Posts navigation

Older posts
Newer posts

Recent Posts

  • ts
  • Healthcare
  • Education
  • Technology
  • Dosage Forms

Recent Comments

    Archives

    • July 2021
    • June 2021

    Categories

    • About us
    • Investors
    • Manufacturing Excellence
    • Media Center
    • Offerings
    • Social
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    ABOUT US

    • Our Manufacturing

    • Our Responsibility

    • JB Worldwide

    • International Partnerships

    • History

    • Management Team

    • Board of Directors

    Contact Us

    Cnergy IT Park,

    Unit A2, 3rd floor & Unit A, 8th floor,
    Appa Saheb Marathe Marg, Prabhadevi,
    Mumbai 400 025.

    Tel: 91-22-2439 5200 / 2439 5500
    Fax: 91-22-2431 5331 / 2431 5334
    Email: info@jbpharma.com

    • Copyright

    • Privacy Policy



    OFFERINGS

    • International Portfolio

    • R&D Innovation

    • Radio Diagnostics

    • Lozenges

    • API

    Therapies at JB

    • Gastroenterology

    • Hypertension

    • Diabetes

    • Dermatology

    • Nephrology

    • Wound Care

    • Anti-Infectives

    • Pharmacovigilance

    INVESTORS

    • Quarterly Results

    • Investor Presentations

    • Annual Reports

    • Investor Resources

    • Press Releases

    • Shareholders' Corner

    • Financial Information

    Media Center

    • Press Releases

    • Media Contact

    CAREERS

    • Life at JB

    • Join Us

    • Privacy Policy

    • Disclaimer

    • JB Next App Disclaimer

    • Sitemap

    Logo
    © 2020 - 2026 JB Pharma. All rights reserved.
    Website Maintain by Synapse